PLATINUM2023

Georgia Center for Oncology Research and Education, Inc.

Advancing Cancer Care through Partnerships and Innovation

aka Georgia CORE   |   Atlanta, GA   |  www.georgiacancerinfo.org
GuideStar Charity Check

Georgia Center for Oncology Research and Education, Inc.

EIN: 57-1159979


Mission

Georgia CORE is a public-private partnership that creates collaborative programs among the state’s cancer organizations and institutions to ensure that Georgians have equitable access to and receive benefits from the latest advances in cancer care and research.

Ruling year info

2005

President & CEO

Lynn Durham

Vice President

Kristina Forbes

Main address

999 Peachtree Street NE Suite 400

Atlanta, GA 30309 USA

Show more contact info

EIN

57-1159979

Subject area info

Community and economic development

Health

Population served info

Adults

Economically disadvantaged people

Women and girls

NTEE code info

Cancer Research (H30)

Research Institutes and/or Public Policy Analysis (E05)

Management & Technical Assistance (S02)

What we aim to solve

SOURCE: Self-reported by organization

Georgia CORE's mission is to advance cancer care through partnerships and innovation. We unite oncologists, public health professionals, researchers and educators in a dynamic collaboration to deliver Clinical research trials with the latest and most promising cancer treatments Screening to detect cancers at early stages when most treatable and potentially curable Genetic services to manage hereditary cancer risk and extend personalized cancer treatment Education and resources to improve quality of life for cancer survivors Advocacy to stimulate impactful investments in cancer among elected officials Georgia CORE is dedicated to improving cancer outcomes and equity of cancer care by serving racial and ethnic minorities and under-resourced communities.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Clinical Trials and Cancer Research

Georgia CORE's focus on increasing access to clinical trials has contributed to an eight-fold expansion in clinical trials and growth of community research across Georgia. The organization facilitates an award winning research network among leading community cancer centers with funding from the National Cancer Institute. 100 oncologists access dozens of clinical trials from 6 regional hubs. Enrollment of racial and ethnic minorities is 25% - 6 times the national average. Enrollment of rural patients is 18% - there are no national benchmarks available. Georgia CORE also participates in cancer care delivery research and comparative effectiveness research.

Population(s) Served
Adults
Economically disadvantaged people

Georgia CORE raises funds for breast cancer screening via sale of the state's breast cancer license tag. The focus is on increasing access to mammography, breast exams and genetic screening among women with greater cancer incidence and mortality rates; 85% of clients are racial or ethnic minorities. In partnership with the State Office of Rural Health over $3.5 million has been granted to 26 community partners for this program. In collaboration with the Georgia Department of Public Health Georgia CORE provides genetic risk assessment, testing and counseling for Hereditary Breast and Ovarian Cancer in 14 health districts. 51% of clients are racial or ethnic minorities. On line risk assessment and resources are available through Georgia CORE's website BreastCancerGeneScreen.org.

Population(s) Served
Women and girls
Economically disadvantaged people

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Patients on Clinical Trials through Georgia National Cancer Institute funded Community Oncology Research Program

This metric is no longer tracked.
Totals By Year
Population(s) Served

People with diseases and illnesses, Ethnic and racial groups, Adults, Economically disadvantaged people, People with disabilities

Related Program

Clinical Trials and Cancer Research

Type of Metric

Outcome - describing the effects on people or issues

Direction of Success

Decreasing

Context Notes

The Georgia NCORP is 1 of 34 organizations in the nation that provides access to the latest NCI cancer clinical trials to patients in their communities. The numbers indicate the program winding down

Number of genetic risk assessments for Hereditary Breast and Ovarian Cancer via BreastCancerGeneScreen.org

This metric is no longer tracked.
Totals By Year
Population(s) Served

Ethnic and racial groups, Social and economic status, Young adults, Pregnant people

Related Program

Breast Cancer Screening & Genetic Risk Assessment

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Context Notes

Women screened in public and community health clinics receive genetic testing, counseling and education prior to a diagnosis of cancer

Number of Visitors Seeking Cancer Information & Resources via GeorgiaCancerInfo.org

This metric is no longer tracked.
Totals By Year
Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Percentage of participants in clinical cancer research by race and ethnicity

This metric is no longer tracked.
Totals By Year
Population(s) Served

Ethnic and racial groups, Chronically ill people, Terminally ill people

Related Program

Clinical Trials and Cancer Research

Type of Metric

Output - describing our activities and reach

Direction of Success

Holding steady

Context Notes

Nationally less than 4% of minorities with cancer participate in clinical research. In Georgia NCORP 6 times more minorities receive the latest and most promising cancer treatments.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

To improve health and quality of life outcomes for patients and survivors by decreasing or eliminating disparities in cancer care. These goals are accomplished through

Collaboration -- delivering high quality programs and services through innovative partnerships and with measurable outcomes
Access -- serving those in areas of greatest need and opportunity to improve cancer prevention, screening and treatment
Equity -- engaging racial and ethnic minorities and survivors at all levels of the organization
Advocacy -- advocating for policies, programs and funding that are evidence-based and address identified needs

Creating statewide access to equitable, inclusive cancer care , research and resources
Expanding the reach of clinical trials and new cancer treatments through personalized medicine
Establishing and funding cancer screening initiatives
Developing and offering education, programs and services focused on survivors
Introducing genetic screening, testing and counseling in public health settings
Providing cancer policy briefings to guide informed investments by lawmakers and public officials
Engaging stakeholders in the development and monitoring of the Georgia Cancer Plan
Disseminating research and outcomes through conferences, whitepapers and peer-reviewed publications

Collaboration -- delivering high quality programs and services through innovative partnerships and with measurable outcomes
Access -- serving those in areas of greatest need and opportunity to improve cancer prevention, screening and treatment
Equity -- engaging racial and ethnic minorities and survivors at all levels of the organization
Advocacy -- advocating for policies, programs and funding that are evidence-based and address identified needs

Facilitating a collaborative community research network for the conduct of cancer clinical trials and cancer care delivery research with funding from the National Cancer Institute;
Expanding screening, treatment, navigation, survivorship and genetics services for high risk and underserved women through a network of public and private partners;
Analyzing the health and economic impact of the state's investments of tobacco settlement funds for cancer;
Providing policy briefings to lawmakers to guide informed investments in cancer care and research;
Creating and sustaining statewide partnerships to develop, implement and track outcomes of the Georgia Cancer Plan;
Providing navigation services and resources to patients, caregivers, survivors and cancer professionals;
Disseminating research and resources through websites, professional conferences, whitepapers and publications;
Providing exceptional management and governance.

Georgia CORE is a public-private partnership that unites experts, survivors, healthcare and cancer-fighting organizations into a single force -- to provide higher quality of care for patients and better quality of life for survivors throughout Georgia. The organization's capabilities are defined by the following assets and resources:

*Board of Directors of multi-disciplinary cancer experts and thought leaders
*Diverse and highly qualified staff; engaged team of volunteers and survivors
*Research network of academic, community and public health centers reaching all corners of the state
*GeorgiaCancerInfo.org a comprehensive online cancer information center and BreastCancerGeneScreen.org for genetic resources and on line genetic risk assessment
*Cancer Survivorship Connection led by an Advisory Board of cancer survivors
*Extensive partnerships among academic and community cancer centers, public health and non profit organizations
*Co-sponsorship of Cancer Patient Navigators of Georgia with the Georgia Society of Clinical Oncology (GASCO) to extend training and support to navigators and caregivers
*Individual contributors, volunteers and community health organizations engaged in supporting breast cancer screening and cancer research.
* Resilience and sustainability driven by strong management and funding from government grants, research contracts and private contributions

Georgia CORE was created fifteen years ago to address the state's disparity in clinical trials and ensure access to the latest research advances so that Georgians could receive the best cancer care close to home. Today Georgia has a reputation as a premier destination for cancer care. Georgia CORE adds to the state’s distinction as a national leader in numerous ways. The results of our programs document an increase in clinical trials accrual in community centers; expansion of clinical trials into rural communities; and reduction of racial and ethnic disparities in research and screening. Georgia CORE’s websites GeorgiaCancerInfo.org and BreastCancerGeneScreen.org fill a critical need for a coordinated and centralized platform that allows patients, caregivers and survivors access to information and resources. Innovative genetic risk assessment, counseling and testing are delivered in public health centers across the state. Legislative advocacy provided by Georgia CORE has contributed to enhancements in state funding for numerous cancer programs. Multiple peer reviewed publications co-authored by Georgia CORE’s staff and partners document these outcomes while recognition from the National Cancer Institute affirms the high level of performance of our research network. All this is accomplished through a unique, cost effective model and there is no other program in the nation quite like ours.

Georgia CORE is evolving in response to dynamic changes in the art and science of oncology care, remaining true to our founding principles, undergoing strategic planning and preparing for long term sustainability. The state’s leading experts in oncology consistently serve on Georgia CORE’s Board of Directors. Their leadership transcends competition to create the culture of cancer collaboration that distinguishes Georgia and makes it possible to develop and nurture a broad consortium of partners -- academic medical centers, community cancer programs, regional cancer coalitions and cancer non-profits. The Board and executive staff have enhanced organizational financial performance by attracting and retaining a talented staff; holding down administrative costs; balancing public and private funding; reducing expenses via a contract with Georgia State University for human resources, payroll and benefits; creating funds for organizational sustainability and future strategic initiatives.

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
NET GAIN/LOSS:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2023 info

SOURCE: IRS Form 990

2.39

Average of 1.85 over 10 years

Months of cash in 2023 info

SOURCE: IRS Form 990

5.4

Average of 4.2 over 10 years

Fringe rate in 2023 info

SOURCE: IRS Form 990

0%

Average of 11% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Georgia Center for Oncology Research and Education, Inc.

Revenue & expenses

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

Georgia Center for Oncology Research and Education, Inc.

Balance sheet

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

Georgia Center for Oncology Research and Education, Inc.

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

This snapshot of Georgia Center for Oncology Research and Education, Inc.’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2018 2019 2020 2021 2023
Unrestricted surplus (deficit) before depreciation $343,317 $397,743 $298,149 $28,592 $566,719
As % of expenses 22.5% 19.6% 15.7% 2.3% 17.0%
Unrestricted surplus (deficit) after depreciation $332,438 $363,761 $232,295 -$18,055 $545,841
As % of expenses 21.6% 17.7% 11.9% -1.4% 16.3%
Revenue composition info
Total revenue (unrestricted & restricted) $1,856,297 $2,317,460 $2,119,383 $1,268,189 $3,851,499
Total revenue, % change over prior year 0.7% 24.8% -8.5% -40.2% 0.0%
Program services revenue 11.3% 17.2% 15.2% 0.0% 0.0%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 0.1% 0.1% 0.0% 0.0% 0.0%
Government grants 88.6% 66.5% 72.6% 93.7% 88.0%
All other grants and contributions 0.0% 16.2% 12.1% 6.3% 11.9%
Other revenue 0.0% 0.0% 0.0% 0.0% 0.1%
Expense composition info
Total expenses before depreciation $1,526,221 $2,024,500 $1,893,234 $1,239,947 $3,329,137
Total expenses, % change over prior year -12.2% 32.6% -6.5% -34.5% 0.0%
Personnel 45.0% 43.1% 47.2% 23.1% 37.7%
Professional fees 12.0% 10.1% 11.0% 25.6% 5.2%
Occupancy 2.2% 1.8% 1.9% 2.0% 2.5%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 19.7% 21.6% 25.2% 36.8% 47.7%
All other expenses 21.1% 23.5% 14.7% 12.5% 6.9%
Full cost components (estimated) info 2018 2019 2020 2021 2023
Total expenses (after depreciation) $1,537,100 $2,058,482 $1,959,088 $1,286,594 $3,350,015
One month of savings $127,185 $168,708 $157,770 $103,329 $277,428
Debt principal payment $0 $0 $0 $0 $0
Fixed asset additions $0 $107,597 $0 $47,453 $0
Total full costs (estimated) $1,664,285 $2,334,787 $2,116,858 $1,437,376 $3,627,443

Capital structure indicators

Liquidity info 2018 2019 2020 2021 2023
Months of cash 4.6 4.8 7.7 10.9 5.4
Months of cash and investments 4.6 4.8 7.7 10.9 5.4
Months of estimated liquid unrestricted net assets 4.4 5.1 8.1 12.2 7.5
Balance sheet composition info 2018 2019 2020 2021 2023
Cash $580,801 $811,248 $1,210,041 $1,121,785 $1,504,853
Investments $0 $0 $0 $0 $0
Receivables $571,255 $790,442 $667,606 $533,114 $1,169,903
Gross land, buildings, equipment (LBE) $77,806 $185,403 $64,954 $55,963 $12,610
Accumulated depreciation (as a % of LBE) 74.6% 49.6% 91.6% 88.8% 84.2%
Liabilities (as a % of assets) 34.8% 39.1% 33.6% 24.2% 23.2%
Unrestricted net assets $585,053 $948,814 $1,284,652 $1,266,597 $2,080,869
Temporarily restricted net assets $199,123 N/A N/A N/A N/A
Permanently restricted net assets $0 N/A N/A N/A N/A
Total restricted net assets $199,123 $94,340 $44,357 $44,357 $0
Total net assets $784,176 $1,043,154 $1,329,009 $1,310,954 $2,080,869

Key data checks

Key data checks info 2018 2019 2020 2021 2023
Material data errors No No No No No

Operations

The people, governance practices, and partners that make the organization tick.

Documents
Letter of Determination is not available for this organization
Form 1023/1024 is not available for this organization

President & CEO

Lynn Durham

With a 25-year career in university administration and management, Lynn is a former Georgia CORE director and volunteer and three-time cancer survivor. Lynn works with partners and the board of directors to lead the organization’s efforts to improve access to clinical trials, as well as personalized cancer care and support for patients, survivors, and caregivers. She also conducts critical outreach on behalf of the organization to state legislators and officials. Lynn spent the majority of her career in higher education administration at Georgia Tech, where she served as associate vice president and chief of staff to President Bud Peterson and later as vice president for Institute Relations. She holds a Doctor of Education degree from the University of Georgia, a master’s degree in Public Administration from Kennesaw State University, and a bachelor’s degree from Radford University in Radford, Virginia.

Vice President

Kristina Forbes

Kristina is passionate about community engagement and service, dedicating her time out of the office towards promoting STEAM opportunities, entrepreneurship, innovation, and youth development. As Georgia CORE’s Vice President for Administration, she will leverage her experience driving organizational growth to impact mission and vision and her significant expertise in operations, events, grant management, fundraising, and human resources. Prior to her current role, Kristina was the Vice President of Operations for the Center for Global Health Innovation, where she created policies and oversaw operations and all revenue generating activities. She also served in business development and fundraising roles for the Technology Association of Georgia, Chi Phi Educational Trust, and the Boy Scouts of America. Kristina graduated from the University of Georgia with a Bachelor of Science in Psychology.

Number of employees

Source: IRS Form 990

Georgia Center for Oncology Research and Education, Inc.

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

Georgia Center for Oncology Research and Education, Inc.

Highest paid employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of highest paid employee data for this organization

Georgia Center for Oncology Research and Education, Inc.

Board of directors
as of 11/03/2023
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board co-chair

Dr. Andrew Pippas

Piedmont Columbus Regional

Term: 2016 - 2024


Board co-chair

Dr. Roland Matthews

Morehouse School of Medicine

Term: 2010 - 2026

Andrew W. Pippas

Piedmont Columbus Regional

Roland Matthews

Morehouse School of Medicine

Frederick M. Schnell

Community Oncology Alliance

Charles H. Nash

Northeast Georgia Medical Center

Sharad A. Ghamande

Georgia Cancer Center, Augusta University

Harvey James Hamrick

Flatiron Health

Amelia A Langston

Winship Cancer Institute, Emory University

Craig Smith

McDermott, Will & Emery

Jorge Cortes

Georgia Cancer Center, Augusta University

Jamie Hodgson

University Cancer and Blood Center

Steven W. McLaughlin

Georgia Institute of Technology

Matt Mumber

Harbin Clinic

Nancy Paris

Suresh Ramalingam

Winship Cancer Institute, Emory University

Stephanie Smith Reyes

Lewis Cancer & Research Pavillion, St. Joseph's/Candler Hospital

Board leadership practices

SOURCE: Self-reported by organization

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section.

  • Board orientation and education
    Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations? Yes
  • CEO oversight
    Has the board conducted a formal, written assessment of the chief executive within the past year ? Yes
  • Ethics and transparency
    Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year? Yes
  • Board composition
    Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership? Yes
  • Board performance
    Has the board conducted a formal, written self-assessment of its performance within the past three years? Yes

Organizational demographics

SOURCE: Self-reported; last updated 12/23/2020

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender
Sexual orientation
Heterosexual or Straight
Disability status
Person without a disability

The organization's co-leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender
Sexual orientation
Heterosexual or Straight
Disability status
Person without a disability

Race & ethnicity

Gender identity

Transgender Identity

Sexual orientation

Disability